Lv1
30 积分 2024-12-03 加入
Structure-Based Optimization of Imidazopyridine Derivatives as Selective and Orally Bioavailable Phosphodiesterase 10A Inhibitors with Reduced Blood–Brain Barrier Penetration for the Treatment of Idiopathic Pulmonary Fibrosis
2个月前
已完结
Function and regulation of the divisome for mitochondrial fission
8个月前
已完结
Repression of peroxisome proliferation-activated receptor γ coactivator-1α by p53 after kidney injury promotes mitochondrial damage and maladaptive kidney repair
8个月前
已完结
Cobaltosic oxide-polyethylene glycol-triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy
8个月前
已完结
Asprosin aggravates vascular endothelial dysfunction via disturbing mitochondrial dynamics in obesity models
8个月前
已完结
cAMP and Mitochondria
8个月前
已完结
Global epidemiology and outcomes of acute kidney injury
8个月前
已完结
Medicinal chemistry strategies for the development of phosphodiesterase 10A (PDE10A) inhibitors - An update of recent progress
8个月前
已完结
Phosphodiesterase 10A inhibitors: a 2009 – 2012 patent update
9个月前
已完结
Activation of β2 adrenergic receptor signaling modulates inflammation: a target limiting the progression of kidney diseases
9个月前
已完结
皖公网安备34019202002308
